![]() |
市場調查報告書
商品編碼
1825964
2025年流式細胞技術全球市場報告Flow Cytometry Global Market Report 2025 |
近年來,流式細胞技術市場規模強勁成長,從2024年的68.8億美元增加至2025年的74.9億美元,複合年成長率為8.8%。預測期內的成長主要歸功於免疫表現型分析、癌症研究、血液學和血球分析、臨床診斷、藥物研發。
預計未來幾年流式細胞技術市場將快速成長,到2029年將達到115億美元,複合年成長率為11.3%。預測期內的成長主要由單細胞分析、免疫療法和CAR-T細胞開發、感染疾病研究、生物標記發現以及即時檢測等驅動。預測期內的主要趨勢包括多色分析、自動化和機器人技術、成像流式細胞技術、數據分析和資訊技術以及樣品製備的創新。
流式細胞技術是一種將細胞導入流體介質中,並使其通過脈衝雷射光束的技術。當細胞將雷射散射到不同方向時,受體會捕捉光並將其轉換為數據顯示在顯示器上。此方法利用雷射光學元件來分析生物細胞的特徵,例如大小、數量和複雜性。
流式細胞技術採用多種技術,包括基於細胞和以微珠為基礎的方法,其應用範圍涵蓋腫瘤學、藥物研發、疾病診斷、幹細胞治療、器官移植和血液學。該技術服務於各種終端用戶,包括醫院和診所、學術和研究機構、製藥和生物技術公司以及其他行業,推動科學研究和醫療保健實踐的發展。
2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療保健領域產生了重大影響,尤其是對基本醫療設備、診斷設備和藥品的供應。醫院和醫療機構正疲於應對進口手術器械、診斷影像系統以及注射器和導管等消耗品不斷上漲的成本,而這些產品中的許多在國內的替代品有限。由於這些不斷上漲的成本給醫療保健預算帶來壓力,一些醫療機構正在推遲設備升級或將增加的費用轉嫁給患者。此外,原料和零件的關稅擾亂了關鍵藥品和醫療設備的生產,導致供應鏈延遲。作為應對措施,該行業正在採用多樣化的籌資策略,盡可能擴大本地生產,並遊說對關鍵醫療產品免關稅。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供流式細胞技術市場統計數據,例如全球流式細胞流式細胞技術市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的流式細胞技術流式細胞技術細分市場、市場趨勢和機遇,以及您在流式細胞技術行業取得成功所需的數據。本流式細胞技術市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的一切觀點。
未來五年11.3%的成長預測較先前的預測略有下降,下降了0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將提高美國從奧地利和新加坡購買的流式細胞技術分析儀和螢光抗體的成本,減緩免疫表現型分析的速度,並增加臨床實驗室的營運成本。互惠關稅以及日益加劇的貿易緊張局勢和限制對全球經濟和貿易的負面影響也將產生更廣泛的影響。
全球HIV感染人數的不斷增加是流式細胞技術市場發展的關鍵驅動力。流式細胞技術利用光散射來區分細胞,並根據細胞的散射模式,用被稱為分化叢集(CD)的特定標記物對其進行標記。例如,2023年10月,英國衛生安全局報告稱,英格蘭的HIV診斷數量增加了22%,從2021年的3,118例增加到2022年的3,805例。隨著全球HIV感染人數的持續上升,對流式細胞技術等診斷方法的需求也在增加。
新藥上市數量的增加也促進了流式細胞技術市場的擴張。新藥上市涉及經過廣泛研發後,透過監管部門核准、行銷和分銷將新藥推向市場。流式細胞技術在新藥上市過程中發揮關鍵作用,它透過評估細胞反應、藥物療效和毒性來確保安全有效的藥物上市。流式細胞技術有助於準確表徵,這對於監管部門核准和上市後監控至關重要。例如,歐洲製藥工業協會聯合會 (European Federation of Pharmaceutical Industries and Associations) 在 2023 年 6 月報告稱,到 2022 年,北美將佔全球藥品銷售額的 52.3%,市場佔有率將比 2021 年的 49.1% 大幅成長。因此,新藥上市數量的增加正在推動流式細胞技術市場的成長。
流式細胞技術市場的主要企業正致力於開發先進產品,例如研究級流式細胞儀,以提高細胞分析的靈敏度和解析度。研究級流式細胞儀用於科學研究,以檢查流經液流的細胞和顆粒的物理和化學特性。這些儀器採用先進的光學系統和軟體,能夠偵測多種螢光標記,為多參數細胞分析提供高靈敏度和解析度。這項技術在免疫學、腫瘤學和細胞生物學等領域至關重要。例如,2024 年 3 月,專門從事生物醫學檢測產品的美國公司貝克曼庫爾特生命科學公司推出了 CytoFLEX 奈米流式細胞儀。該系統可以檢測到小至 40 奈米的奈米顆粒,使其能夠有效地分析細胞外囊泡 (EV) 和其他奈米級實體。憑藉 1 μm 至 40 nm 的靈敏度和 10 nm 的解析度,它可以檢測到 EV 內的低豐度物質。這種提高的靈敏度對於準確表徵小顆粒群至關重要。該系統配備六個螢光和五個側向散射通道,可同時收集多個參數的大量數據。此外,它還包含 CytExpert nano 軟體,該軟體支援高級研究,同時提供直覺的介面,簡化複雜的分析。
流式細胞技術市場的公司也專注於開發創新產品,例如自動化樣品製備系統,可減少技術人員的時間,同時提供更快、更準確的結果。自動化樣品製備系統透過自動執行混合、染色和稀釋等任務來簡化實驗室流程,確保樣品製備的一致性和準確性。這不僅最大限度地減少了人工,還提高了效率,使其成為高性能實驗室和臨床診斷的理想選擇。例如,美國醫療設備公司Becton Dickinson於2023年6月推出了BD FACSDuet。這款高階樣品製備系統旨在與BD FACSLyric臨床流式細胞技術系統無縫整合,實現全自動「無人值守」工作流程。它可自動執行樣品混合、清洗和離心等關鍵流程。樣品製備後,無需人工干預即可將樣品轉移到流式細胞儀,從而減少了手動步驟和操作時間。該系統顯著提高了臨床診斷的標準化和可重複性,並提高了實驗室的整體效率。
2022年2月,總部位於美國的GLP和GCP合規開發服務供應商KCAS Bioanalytical and Biomarker Services收購了FlowMetric LLC,收購金額未揭露。此次收購預計將增強KCAS在分析測試領域的能力。 FlowMetric是一家總部位於美國的流式細胞技術和細胞檢測服務提供者。
流式細胞儀市場的主要企業包括 Beckman Coulter Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、Thermo Fisher Scientific Inc.、Luminex Corporation、Miltenyi BIoTec Ltd.、Becton Dickinson and Company、Sysmex Corporation、Merck KGaA、Docistal Corporation.Dcx 流式細胞技術 Corporation.公司、Affymetrix Inc.、Biomerieux SA、Cytonome St LLC、Enzo Life Sciences Inc.、Sony Biotechnology Inc.、Life Technologies Corporation、ACEA Biosciences Inc.、Takara Bio Inc.、Union Biometrica Inc.、Cytek Biosciences Inc Cy.、Nexcelom Bioscience LLC、Verity Software
2024年,流式細胞技術市場最大的地區是北美。西歐是流式細胞技術市場分析的第二大地區。流式細胞技術市場報告涵蓋以下地區:亞太地區、西歐、東歐、北美、南美以及中東和非洲。
流式細胞技術市場報告涵蓋的國家:澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙
流式細胞技術市場涵蓋流式細胞儀系統、檢測板製造商和儀器的收益。市場規模包括服務供應商銷售或包含在其服務產品中的相關商品的價值。僅包括企業之間交易或銷售給最終消費者的商品和服務。
Flow cytometry is a technique where cells are introduced into a fluid medium that is passed through a pulsating laser beam. As the cells scatter the laser beam in various directions, receptors capture the light and convert it into data displayed on a monitor. This method is used to analyze biological cell characteristics, such as size, count, and complexity, utilizing laser optics.
Flow cytometry employs different technologies, including cell-based and bead-based methods, with applications spanning oncology, drug discovery, disease diagnosis, stem cell therapy, organ transplantation, and hematology. This technology serves a diverse range of end-users, including hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, as well as other sectors, to advance scientific research and healthcare practices.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The flow cytometry market research report is one of a series of new reports from The Business Research Company that provides flow cytometry market statistics, including flow cytometry industry global market size, regional shares, competitors with a flow cytometry market share, detailed flow cytometry market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry industry. This flow cytometry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The flow cytometry market size has grown strongly in recent years. It will grow from $6.88 billion in 2024 to $7.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to immunophenotyping, cancer research, hematology and blood cell analysis, clinical diagnostics, drug discovery and development.
The flow cytometry market size is expected to see rapid growth in the next few years. It will grow to $11.5 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to single-cell analysis, immunotherapy and car-t cell development, infectious disease research, biomarker discovery, point-of-care testing (poct). Major trends in the forecast period include multicolor analysis, automation and robotics, imaging flow cytometry, data analysis and informatics, sample preparation innovations.
The forecast of 11.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of flow cytometry analyzers and fluorescent antibodies sourced from Austria and Singapore, thereby slowing immunophenotyping and elevating clinical lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising global number of HIV cases is a key driver for the flow cytometry market, as this technique plays a direct role in HIV diagnosis. Flow cytometry utilizes light scattering to identify cells, which are labeled with specific markers known as CDs (clusters of differentiation) based on the scattering pattern. For example, in October 2023, the UK Health Security Agency reported a 22% increase in HIV diagnoses in England, rising from 3,118 cases in 2021 to 3,805 in 2022. As the global HIV population continues to rise, the demand for diagnostic methods like flow cytometry is also growing.
The growth in drug launches has also contributed to the expansion of the flow cytometry market. Drug launches involve introducing new pharmaceutical products to the market, following regulatory approval, marketing, and distribution after extensive research and development. Flow cytometry plays a critical role in drug launches by evaluating cellular responses, drug efficacy, and toxicity, ensuring that safe and effective medications are brought to market. It helps with accurate characterizations essential for regulatory approval and post-launch monitoring. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations reported that North America accounted for 52.3% of global pharmaceutical sales in 2022, up from 49.1% in 2021, highlighting a significant market share increase. Thus, the rise in drug launches is driving growth in the flow cytometry market.
Leading companies in the flow cytometry market are concentrating on the development of advanced products, such as research-grade flow cytometers, to improve the sensitivity and resolution of cell analysis. Research-grade flow cytometers are used in scientific studies to examine the physical and chemical properties of cells or particles as they pass through a fluid stream. These devices provide high sensitivity and resolution for multiparametric cellular analysis, featuring advanced optical systems and software that can detect multiple fluorescent markers. They are crucial in fields like immunology, oncology, and cell biology. For example, in March 2024, Beckman Coulter Life Sciences, a US-based company specializing in biomedical testing products, introduced the CytoFLEX nanoflow cytometer. This system is capable of detecting nanoparticles as small as 40 nm, making it highly effective for analyzing extracellular vesicles (EVs) and other nanoscale entities. It offers a sensitivity range from 1 µm to 40 nm, with a resolution of 10 nm, allowing for the detection of low-abundance cargo within EVs. This enhanced sensitivity is crucial for accurately characterizing small particle populations. The system features 6 fluorescent channels and 5 side scatter channels, enabling extensive data collection across multiple parameters simultaneously. It is also equipped with CytExpert nano software, which provides an intuitive interface for simplifying complex analyses while supporting advanced research.
Companies in the flow cytometry market are also focused on developing innovative products such as automated sample preparation systems to deliver faster, more accurate results while reducing hands-on time for technicians. An automated sample preparation system streamlines laboratory processes by automating tasks such as mixing, staining, and dilution, ensuring consistent and precise sample preparation. This not only minimizes manual effort but also enhances efficiency, making it ideal for high-throughput labs and clinical diagnostics. For example, in June 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD FACSDuet. This premium sample preparation system is designed to integrate seamlessly with the BD FACSLyric clinical flow cytometry system, enabling a fully automated "walkaway" workflow. It automates critical processes, including cocktailing, washing, and centrifuging of samples. Once prepared, the samples are transferred to the flow cytometer with no human intervention, reducing manual steps and hands-on time. This system significantly improves standardization and reproducibility in clinical diagnostics, boosting overall lab efficiency.
In February 2022, KCAS Bioanalytical and Biomarker Services, a US-based development service provider compliant with GLP and GCP standards, acquired FlowMetric LLC for an undisclosed amount. This acquisition is expected to bolster KCAS's capabilities in the field of analytical testing. FlowMetric is a US-based provider of flow cytometry and cellular assay services.
Major companies operating in the flow cytometry market include Beckman Coulter Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Luminex Corporation, Miltenyi Biotec Ltd., Becton Dickinson and Company, Sysmex Corporation, Merck KGaA, Danaher Corporation, Apogee Flow Systems Ltd., Stratedigm Inc., General Electric Company, EMD Millipore Corporation, Affymetrix Inc., Biomerieux SA, Cytonome St LLC, Enzo Life Sciences Inc., Sony Biotechnology Inc., Life Technologies Corporation, ACEA Biosciences Inc., Takara Bio Inc., Union Biometrica Inc., Cytek Biosciences Inc., Nexcelom Bioscience LLC, Verity Software House Inc., Spectral Cytometry Systems GmbH, InstruNor AS
North America was the largest region in the flow cytometry market in 2024. Western Europe was the second largest region in the flow cytometry market analysis. The regions covered in the flow cytometry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the flow cytometry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The flow cytometry market includes revenue earned by cytometry systems, panel builders, and instruments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Flow Cytometry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on flow cytometry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for flow cytometry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The flow cytometry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.